MARKET

OPK

OPK

Opko Health
NASDAQ
1.480
+0.020
+1.37%
After Hours: 1.478 -0.002 -0.13% 19:57 08/21 EDT
OPEN
1.470
PREV CLOSE
1.460
HIGH
1.520
LOW
1.455
VOLUME
2.66M
TURNOVER
--
52 WEEK HIGH
1.730
52 WEEK LOW
0.9769
MARKET CAP
1.10B
P/E (TTM)
-15.3368
1D
5D
1M
3M
1Y
5Y
1D
SA Asks: What are the most promising oncology companies right now?
Seeking Alpha · 20h ago
Opko’s CTAP101 Pediatric Trial: A New Angle on Kidney Care Growth
TipRanks · 3d ago
OPKO Health (OPK) Stock Looks Stretched On Fresh Royalty Backed Financing
Simply Wall St · 3d ago
OPK Raises $125 Million Against Royalties: What Investors Should Know
NASDAQ · 4d ago
Is OPK Worth Buying as Valuation Meets Improving Business Trends?
NASDAQ · 4d ago
OPK Climbs 12.4% in the Past Month: Can the Stock Rally Keep Going?
NASDAQ · 4d ago
Should OPKO Health’s Royalty-Backed US$125 Million Financing Shift Matter to OPKO Health (OPK) Investors?
Simply Wall St · 6d ago
Weekly Report: what happened at OPK last week (0810-0814)?
Weekly Report · 6d ago
More
About OPK
OPKO Health, Inc. is a multinational biopharmaceutical and diagnostics company. The Company’s segments include pharmaceutical and diagnostics. The pharmaceutical segment consists of the pharmaceutical operations it operates in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its global pharmaceutical research and development operations. The diagnostics segment primarily consists of clinical laboratory operations through BioReference and its point-of-care operations. Its pharmaceutical business features Somatrogon (hGH-CTP), a once-weekly human growth hormone injection, and it is marketed under the brand name NGENLA. The Company, through its pharmaceutical division, manufactures and sells Rayaldee, a United States Food and Drug Administration (FDA) approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency.

Webull offers OPKO Health Inc stock information, including NASDAQ: OPK real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OPK stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading OPK stock methods without spending real money on the virtual paper trading platform.